TREM1 and inflammation: The enhanced inflammatory response in macrophages has been indicated as a mechanism by which TREM-1 signaling contributes to lung injury; therefore, inhibition of TREM-1 is a potential therapeutic strategy for neutrophil lung inflammation and ARDS [32].